Gan & Lee Pharmaceuticals. (SHA: 603087)
China flag China · Delayed Price · Currency is CNY
48.42
-1.26 (-2.54%)
Nov 13, 2024, 3:00 PM CST

Gan & Lee Pharmaceuticals. Company Description

Gan & Lee Pharmaceuticals., a biopharmaceutical company, engages in the research, development, production, and sale of insulin analog active pharmaceutical ingredients (APIs) and injections in China.

The company’s products include Basalin, an insulin glargine injection; Prandilin, an insulin lispro and lispro mix 75/25 injection; Prandilin 25, an insulin lispro injection; Rapilin, an insulin aspart injection; Rapilin 30, an insulin aspart 30 injection; and Similin 30, an insulin injection.

It also offers GanleePen, an insulin injection device; GanleeFine, an insulin pen needle; and medical devices.

The company was formerly known as Beijing Gan & Lee Biotechnology Co., Ltd. and changed its name to Gan & Lee Pharmaceuticals.

in April 2005. Gan & Lee Pharmaceuticals.

was founded in 1998 and is headquartered in Beijing, the People’s Republic of China.

Gan & Lee Pharmaceuticals.
Gan & Lee Pharmaceuticals. logo
Country China
Founded 1998
Industry Medical Instruments & Supplies
Sector Healthcare
Employees 4,482
CEO Kai Du

Contact Details

Address:
No. 8, Nanfeng West 1st Street
Beijing, 101109
China
Phone 86 10 8059 3699
Website ganlee.com

Stock Details

Ticker Symbol 603087
Exchange Shanghai Stock Exchange
Fiscal Year January - December
Reporting Currency CNY
ISIN Number CNE100003ZH1
SIC Code 2836

Key Executives

Name Position
Gan Zhongru Founder and Chairman
Kai Du GM and Director
Cheng Sun Chief Financial Officer and Deputy GM
Wei Chen Deputy GM and Director
Weiqiang Song Deputy GM and Director
Rong Zou Secretary
Cheng Xing Deputy General Manager
Zifei Yuan Deputy General Manager
Zhi Li Deputy General Manager